From Molecule to Market: The Future of Precision Medicine Commercialization
By Erik Rush Precision medicine has moved beyond promise and far beyond theory. Biomarker-driven therapies, companion diagnostics, genomic profiling, targeted oncology treatments, cell and gene therapies, and increasingly sophisticated data analytics are changing how diseases are identified and treated. But […]









